JP2018500322A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018500322A5 JP2018500322A5 JP2017532039A JP2017532039A JP2018500322A5 JP 2018500322 A5 JP2018500322 A5 JP 2018500322A5 JP 2017532039 A JP2017532039 A JP 2017532039A JP 2017532039 A JP2017532039 A JP 2017532039A JP 2018500322 A5 JP2018500322 A5 JP 2018500322A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic composition
- composition according
- years
- vzv
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1422686.4 | 2014-12-18 | ||
| GB201422686 | 2014-12-18 | ||
| GB1503266.7 | 2015-02-26 | ||
| GB201503266A GB201503266D0 (en) | 2015-02-26 | 2015-02-26 | Vaccination |
| GB1518917.8 | 2015-10-26 | ||
| GBGB1518917.8A GB201518917D0 (en) | 2015-10-26 | 2015-10-26 | Vaccination |
| PCT/EP2015/079967 WO2016096968A1 (en) | 2014-12-18 | 2015-12-16 | Vaccination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018500322A JP2018500322A (ja) | 2018-01-11 |
| JP2018500322A5 true JP2018500322A5 (https=) | 2018-12-27 |
Family
ID=54937057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017532039A Pending JP2018500322A (ja) | 2014-12-18 | 2015-12-16 | ワクチン接種 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20180008700A1 (https=) |
| EP (1) | EP3233118A1 (https=) |
| JP (1) | JP2018500322A (https=) |
| CN (1) | CN107106675A (https=) |
| BR (1) | BR112017012647A2 (https=) |
| CA (1) | CA2970840A1 (https=) |
| MX (1) | MX2017008055A (https=) |
| WO (1) | WO2016096968A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017070601A1 (en) * | 2015-10-22 | 2017-04-27 | Modernatx, Inc. | Nucleic acid vaccines for varicella zoster virus (vzv) |
| CN108778289B (zh) | 2015-11-06 | 2020-11-17 | 佐剂技术公司 | 三萜皂苷类似物 |
| CA3061205A1 (en) | 2017-04-25 | 2018-11-01 | Memorial Sloan Kettering Cancer Center | Triterpene saponin analogues |
| CN110621339A (zh) * | 2017-04-28 | 2019-12-27 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗接种 |
| BR112020023642A2 (pt) * | 2018-05-23 | 2021-02-17 | Mogam Institute For Biomedical Research | variante de antígeno de vírus de varicela zoster e uso da mesma |
| CN109602901B (zh) * | 2019-01-08 | 2022-05-27 | 成都迈科康生物科技有限公司 | 一种带状疱疹病毒疫苗及其制备方法和应用 |
| US12070495B2 (en) | 2019-03-15 | 2024-08-27 | Modernatx, Inc. | HIV RNA vaccines |
| IL292796A (en) * | 2019-11-05 | 2022-07-01 | Adjuvance Tech Inc | Varicella zoster immunogenic compositions and uses thereof |
| BR112022017852A2 (pt) | 2020-03-09 | 2022-11-01 | Dynavax Tech Corp | Vacinas para herpes zoster compreendendo um agonista de tlr9 |
| EP4526327A1 (en) * | 2022-05-20 | 2025-03-26 | GlaxoSmithKline Biologicals S.A. | Modified varicella zoster virus glycoprotein e proteins |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0504436D0 (en) * | 2005-03-03 | 2005-04-06 | Glaxosmithkline Biolog Sa | Vaccine |
| TWI457133B (zh) * | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
-
2015
- 2015-12-16 EP EP15813347.0A patent/EP3233118A1/en not_active Withdrawn
- 2015-12-16 WO PCT/EP2015/079967 patent/WO2016096968A1/en not_active Ceased
- 2015-12-16 CA CA2970840A patent/CA2970840A1/en active Pending
- 2015-12-16 MX MX2017008055A patent/MX2017008055A/es unknown
- 2015-12-16 JP JP2017532039A patent/JP2018500322A/ja active Pending
- 2015-12-16 US US15/535,723 patent/US20180008700A1/en not_active Abandoned
- 2015-12-16 BR BR112017012647A patent/BR112017012647A2/pt not_active Application Discontinuation
- 2015-12-16 CN CN201580068948.3A patent/CN107106675A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018500322A5 (https=) | ||
| US20230116042A1 (en) | Adjuvant formulations comprising tlr4 agonists and methods of using the same | |
| EP2664332B1 (en) | Vaccine composition containing synthetic adjuvant | |
| Kamphuis et al. | Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats | |
| US11951161B2 (en) | Methods for inducing an immune response | |
| JP2003523310A (ja) | 新規インフルエンザウイルスワクチン組成物 | |
| HUP0203817A2 (hu) | Polioxietilén-alkil-étert vagy -észtert és legalább egy nemionos felületaktív anyagot tartalmazó adjuváns | |
| HUP0202885A2 (hu) | Oltóanyagok | |
| BRPI0716959A2 (pt) | Composição de vacina contendo adjuvante sintético | |
| JP2018500322A (ja) | ワクチン接種 | |
| JP2017511327A5 (https=) | ||
| CN110621339A (zh) | 疫苗接种 | |
| JP2017511324A5 (https=) | ||
| CA3157372A1 (en) | Varicella zoster | |
| Silveira et al. | Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice | |
| WO2012042003A1 (en) | Improved vaccine compositions | |
| EP3119428B1 (en) | Toll-like receptor 2 agonists and vaccines and uses thereof | |
| AR103030A1 (es) | Composición inmunógena | |
| Lee | EFFECTS OF VACCINE PLATFORMS AND ADJUVANTS ON PROTECTIVE EFFICACY AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS | |
| HK1191545B (en) | Vaccine composition containing synthetic adjuvant |